nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadopentetate dimeglumine—Stomach ache—Octreotide—thymus cancer	0.0464	0.0568	CcSEcCtD
Gadopentetate dimeglumine—PGD—neck—thymus cancer	0.0361	0.197	CbGeAlD
Gadopentetate dimeglumine—Burning sensation—Octreotide—thymus cancer	0.0284	0.0347	CcSEcCtD
Gadopentetate dimeglumine—Throat sore—Octreotide—thymus cancer	0.0274	0.0335	CcSEcCtD
Gadopentetate dimeglumine—Oropharyngeal discomfort—Octreotide—thymus cancer	0.0271	0.0332	CcSEcCtD
Gadopentetate dimeglumine—PGD—hematopoietic system—thymus cancer	0.0268	0.147	CbGeAlD
Gadopentetate dimeglumine—Injection site pain—Octreotide—thymus cancer	0.0242	0.0296	CcSEcCtD
Gadopentetate dimeglumine—Oropharyngeal pain—Octreotide—thymus cancer	0.0217	0.0265	CcSEcCtD
Gadopentetate dimeglumine—Hearing impaired—Octreotide—thymus cancer	0.0207	0.0254	CcSEcCtD
Gadopentetate dimeglumine—PGD—cardiac atrium—thymus cancer	0.0204	0.112	CbGeAlD
Gadopentetate dimeglumine—PGD—pituitary gland—thymus cancer	0.0199	0.109	CbGeAlD
Gadopentetate dimeglumine—Injection site reaction—Octreotide—thymus cancer	0.0196	0.024	CcSEcCtD
Gadopentetate dimeglumine—Wheezing—Octreotide—thymus cancer	0.0192	0.0234	CcSEcCtD
Gadopentetate dimeglumine—PGD—lymphoid tissue—thymus cancer	0.0189	0.103	CbGeAlD
Gadopentetate dimeglumine—PGD—bone marrow—thymus cancer	0.0172	0.0942	CbGeAlD
Gadopentetate dimeglumine—PGD—thyroid gland—thymus cancer	0.0172	0.0939	CbGeAlD
Gadopentetate dimeglumine—Phlebitis—Octreotide—thymus cancer	0.0166	0.0203	CcSEcCtD
Gadopentetate dimeglumine—Thrombophlebitis—Octreotide—thymus cancer	0.0165	0.0202	CcSEcCtD
Gadopentetate dimeglumine—Deafness—Octreotide—thymus cancer	0.016	0.0196	CcSEcCtD
Gadopentetate dimeglumine—PGD—lung—thymus cancer	0.0156	0.0853	CbGeAlD
Gadopentetate dimeglumine—Visual disturbance—Octreotide—thymus cancer	0.0151	0.0185	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactoid reaction—Octreotide—thymus cancer	0.0148	0.0181	CcSEcCtD
Gadopentetate dimeglumine—Pain in extremity—Octreotide—thymus cancer	0.0143	0.0175	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain upper—Octreotide—thymus cancer	0.0131	0.016	CcSEcCtD
Gadopentetate dimeglumine—Nasopharyngitis—Octreotide—thymus cancer	0.0128	0.0157	CcSEcCtD
Gadopentetate dimeglumine—Bronchospasm—Octreotide—thymus cancer	0.0122	0.0149	CcSEcCtD
Gadopentetate dimeglumine—Abdominal discomfort—Octreotide—thymus cancer	0.0119	0.0145	CcSEcCtD
Gadopentetate dimeglumine—Pollakiuria—Octreotide—thymus cancer	0.0114	0.014	CcSEcCtD
Gadopentetate dimeglumine—Drowsiness—Octreotide—thymus cancer	0.011	0.0135	CcSEcCtD
Gadopentetate dimeglumine—Conjunctivitis—Octreotide—thymus cancer	0.0107	0.0131	CcSEcCtD
Gadopentetate dimeglumine—PGD—lymph node—thymus cancer	0.0107	0.0584	CbGeAlD
Gadopentetate dimeglumine—Hepatobiliary disease—Octreotide—thymus cancer	0.0104	0.0128	CcSEcCtD
Gadopentetate dimeglumine—Bradycardia—Octreotide—thymus cancer	0.0101	0.0123	CcSEcCtD
Gadopentetate dimeglumine—Rhinitis—Octreotide—thymus cancer	0.00993	0.0122	CcSEcCtD
Gadopentetate dimeglumine—Oedema peripheral—Octreotide—thymus cancer	0.00976	0.0119	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Octreotide—thymus cancer	0.00955	0.0117	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Octreotide—thymus cancer	0.00924	0.0113	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Octreotide—thymus cancer	0.0092	0.0113	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Octreotide—thymus cancer	0.0092	0.0113	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Octreotide—thymus cancer	0.00895	0.0109	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Octreotide—thymus cancer	0.00885	0.0108	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Octreotide—thymus cancer	0.00868	0.0106	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Octreotide—thymus cancer	0.00863	0.0106	CcSEcCtD
Gadopentetate dimeglumine—Tension—Octreotide—thymus cancer	0.00846	0.0104	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Octreotide—thymus cancer	0.00834	0.0102	CcSEcCtD
Gadopentetate dimeglumine—Tremor—Octreotide—thymus cancer	0.00808	0.00989	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Octreotide—thymus cancer	0.00793	0.0097	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Octreotide—thymus cancer	0.00778	0.00952	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Octreotide—thymus cancer	0.00773	0.00946	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Octreotide—thymus cancer	0.00758	0.00928	CcSEcCtD
Gadopentetate dimeglumine—Cough—Octreotide—thymus cancer	0.00753	0.00921	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Octreotide—thymus cancer	0.00747	0.00914	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Octreotide—thymus cancer	0.00745	0.00911	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Octreotide—thymus cancer	0.00734	0.00898	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Octreotide—thymus cancer	0.00734	0.00898	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Octreotide—thymus cancer	0.00732	0.00895	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00729	0.00892	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Octreotide—thymus cancer	0.00718	0.00879	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Octreotide—thymus cancer	0.00704	0.00861	CcSEcCtD
Gadopentetate dimeglumine—Shock—Octreotide—thymus cancer	0.00693	0.00847	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Octreotide—thymus cancer	0.0069	0.00845	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Octreotide—thymus cancer	0.00687	0.00841	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Octreotide—thymus cancer	0.00684	0.00837	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Octreotide—thymus cancer	0.00681	0.00833	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Octreotide—thymus cancer	0.00671	0.00821	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00641	0.00785	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Octreotide—thymus cancer	0.00632	0.00773	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Octreotide—thymus cancer	0.00628	0.00768	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Octreotide—thymus cancer	0.00626	0.00766	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Octreotide—thymus cancer	0.00612	0.00749	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Octreotide—thymus cancer	0.00608	0.00744	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Octreotide—thymus cancer	0.00607	0.00743	CcSEcCtD
Gadopentetate dimeglumine—Pain—Octreotide—thymus cancer	0.00602	0.00737	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Octreotide—thymus cancer	0.00602	0.00737	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Octreotide—thymus cancer	0.0058	0.0071	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Octreotide—thymus cancer	0.00576	0.00704	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Octreotide—thymus cancer	0.00559	0.00684	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Octreotide—thymus cancer	0.00556	0.00681	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Octreotide—thymus cancer	0.00556	0.00681	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Octreotide—thymus cancer	0.00519	0.00635	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Octreotide—thymus cancer	0.00505	0.00618	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Octreotide—thymus cancer	0.00498	0.00609	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Octreotide—thymus cancer	0.00482	0.00589	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Octreotide—thymus cancer	0.00465	0.0057	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Octreotide—thymus cancer	0.00448	0.00548	CcSEcCtD
Gadopentetate dimeglumine—Rash—Octreotide—thymus cancer	0.00444	0.00543	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Octreotide—thymus cancer	0.00443	0.00543	CcSEcCtD
Gadopentetate dimeglumine—Headache—Octreotide—thymus cancer	0.00441	0.0054	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Octreotide—thymus cancer	0.00418	0.00512	CcSEcCtD
